Company Overview and News

 
BWP posts big profit lift

2016-08-04 businessnews.com.au
Bunnings’ property arm BWP Trust has posted a solid 48 per cent increase in net profit for the 2016 financial year, backed by higher rental growth.

 
Markets Live: ASX rally faces big tests

2016-08-01 theage.com.au
Shares are set to open higher with the start of reporting season proper and the RBA's rates decision tomorrow key tests for the extended post-Brexit rally.

 
Markets Live: ASX rally faces big tests

2016-08-01 smh.com.au
Shares are set to open higher with the start of reporting season proper and the RBA's rates decision tomorrow key tests for the extended post-Brexit rally.

 
RBA and Rio Tinto star in busy week ahead

2016-07-31 theage.com.au
It's a big week ahead for investors, savers, and homeowners as company profits season kicks off in earnest and the RBA meets to decide whether to once again lower its cash rate target.

 
RBA and Rio Tinto star in busy week ahead

2016-07-31 smh.com.au
It's a big week ahead for investors, savers, and homeowners as company profits season kicks off in earnest and the RBA meets to decide whether to once again lower its cash rate target.

 
Intelligent Investor: what to do when sharemarket yield becomes expensive

2016-06-07 smh.com.au
For 20 years now, Japanese interest rates haven't risen above 1 per cent. The demand for safes over that period barely budged. Japanese savers weren't getting much in the way of returns but at least they got something.

 
Australian Dividend Stocks In Focus

2016-03-16 seekingalpha
The Australian stock market is filled with dividend stocks with high yields and payout ratios. That's because of differences in taxation that make dividend payments more appealing for Australian businesses than for United States businesses.

 
Change in substantial holding

2016-03-11 asx.com.au

 
Stocks end five-day losing streak

2016-02-11 at.theaustralian.com.au
The Australian sharemarket has ended a four-day losing streak, closing higher amid some strong earnings results from Cochlear and listed property trusts.

 
Aust stocks end losing streak, close 1% higher

2016-02-11 heraldsun.com.au
Aust stocks end losing streak, close 1% higher

 
 
2015-16 Half-year Report

2016-02-11 asx.com.au

 

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...